Gene manufacturing platforms, patient-centric formulations, contract services, packaging innovations, and sterile filling lines are in the spotlight at CPHI Milan 2026.
News|Articles|October 28, 2019
Telstar to Present New Devices and Manufacturing Processes at CPhI Worldwide 2019
Author(s)Pharmaceutical Technology Editors
The company will showcase new solutions for isolation technology systems, sterilization, and pharmaceutical freeze-drying applications at the event.
Advertisement
Telstar, an aseptic process solutions company based in Spain, announced it will be presenting new solutions for isolation technology systems, sterilization, and pharmaceutical freeze-drying applications from Nov. 5–7, 2019 at CPhI Worldwide in Frankfurt, Germany.
According to an Oct. 25, 2019 press release, the company will showcase a number of new freeze-drying systems and aseptic manufacturing processes including:
- Lyogistics Zero, an automatic vial loading and unloading system for freeze-drying which can be cleaned and sterilized inside a freeze-drying chamber.
- Lyonuc, a nucleation induction method that reduces the duration of the primary drying cycle and ensures the uniformity and homogenization of the vials in batches for any type of freeze dryer.
- Lyomega SV, a single-vessel GMP production freeze dryer used to maintain a conventional workspace while producing a footprint up to 20% smaller than a lyophilizer with standard external condenser configuration.
- Lyogistics Smart R3, an automated inline vial management device with the ability to reject, reintroduce, and retrieve vials during the loading and unloading process into freeze dryers.
- Telstar Lyosensing, a process analyzer used to monitor the freeze-drying cycle and detect and prevent real and virtual leaks in freeze dryers.
- Telstar Lyometrics, a soft-sensor temperature monitoring system in industrial freeze dryers with automatic loading and unloading systems that provide on-line monitoring of the global batch product temperature during primary drying.
- HVAC control systems for clean rooms that save over 40% in energy consumption while enabling the systems to reduce the frequency of air renovation cycles and to reach the maximum level permitted of particles in the room.
- Sterility test isolators used with the company’s ionHP+ bio-decontamination system to increase time available for process and reduce running costs.
Telstar will be presenting its new products at booth 110D32 at CPhI Worldwide.
Source:
Advertisement
Related to this article
Hovione's $35M CDC Flex line links spray drying to tablets, designed to eliminate scale-up under FDA Q13 guidance.
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.
Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical and costly. They recommend setting scientifically justified, risk-based limits and consistently staying below them.
Ron Scarboro, Azurity Pharmaceuticals, claims drug reformulation that removes patient barriers must preserve efficacy, urging early cross-functional team alignment.
PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Advertisement
Advertisement